Concepedia
Statistics
Publications
14
Citations
3.9K
H-Index
Active since
1989
Affiliations
University of Pittsburgh(Current)
The University of Texas at San Antonio Health Science Center
Cedars-Sinai Medical Center
Mayo Clinic in Arizona
Moffitt Cancer Center
David Roodman is an author at University of Pittsburgh specializing in medicine, multiple myeloma, and multiple myeloma therapy.
Publications per year
1989–2023
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
D. E. Hughes, Kenneth R. Wright, Harry L. Uy et al. · Journal of Bone and Mineral Research · 1995 · 1K citations
Medicine, Cell Biology, Pharmacology +17
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations
Medicine, Hematology, Pharmacotherapy +15
Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro
Johannes Pfeilschifter, Chantal Chenu, Andrew Bird et al. · Journal of Bone and Mineral Research · 1989 · 472 citations
Medicine, Cell Biology, Immunology +13
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
Brian G.M. Durie, Robert A. Kyle, Andrew R. Belch et al. · The Hematology Journal · 2003 · 425 citations
Medicine, Hematology, Internal Medicine +16
American Society of Clinical Oncology 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma
Robert A. Kyle, Gary C. Yee, Mark R. Somerfield et al. · Journal of Clinical Oncology · 2007 · 409 citations · Full text
Medicine, Oncology, Bone Metabolism +15
1–5 of 14